Prescribed Medicines in Wales - some observations

It's the value of the 'treatment' that counts - not only the cost the medicines


Patient logistics, desires and needs may also influence choice
In general, evidence still suggests patients are overtreated with meds, though in some areas of therapeutics, undertreatment is common
Avoiding unnecessary treatment helps everyone.
If the treatment is to provide the benefits we expect, it also has to be possible, and, easy, for the patient to consume it
Taking the time to get to that point is a challenge - but pharmacy staff, specialist nurses, and PhAs in primary care, offer a resource that is likely cost effective for this role

References here [In progress]


All the same, everything else being equal, choosing cost effective medicines keeps the money in the NHS.

Now a race against new variants - but still making good progress


via GIPHY



Updates - see Updates

  • Figures and graphs for one Health Board see this site - Powys
  • Updated subsection line graphs to December 2020 data (latest available)
  • Legends (mostly) sorted
  • new image in production............
  • Preparation for highlighting fast growth areas - first, and second, prototypes (see nav bar above)

Plans for next steps, see this page

Why might you want this, when you have Caspa, SPIRA, and other rich data visualisations?

Its fast and convenient....

if you have suggestions/requests, send them to information@powysrx.co.uk


  • Where the data comes from, and other credits

    Powys subsections These are all up to date to December 2020 data (most recent) - some other pages are only up to August or September 2020, while I work for TTP

    Display of legends for subsections with lots of chemicals is almost right, now.

    See nav bar above for link to all Wales data


    What impact has Covid 19 had? Just testing…..


External Version